Anti-Human HLA-DR Antibody, clone L243 | PA007453
Recombinant Mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant Mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant Hamster IgG2 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
Recombinant human IgG antibody mixes: animal free production; lot-to-lot consistency; no binding to human tissues; adjustable formulation of the human IgG antibodies in the antibody mixes. Best normal human serum alternative; normal human serum blocking...
Recombinant rat IgG2b isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.
The human CD16 Fc blocking antibody (3G8 Fc blocking antibody) is an anti-human Fc receptor antibody for human FcR blocking reagent. Various isotypes are available for certain applications. Condition of sample preparation and optimal sample...
Recombinant anti-biotin antibodies and mutants good for in vitro and in vivo studies. The variable regions were not humanized in the human antibody versions.
Recombinant human IgG antibody mixes: animal free production; lot-to-lot consistency; no binding to human tissues; adjustable formulation of the human IgG antibodies in the antibody mixes. Best normal human serum alternative; normal human serum blocking...
Recombinant mouse IgG2a isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally by the investigator.